109,420.00
-2,420.00
(-2.16%)
At close: January 24 at 10:19:19 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 5 | 22 | 21 |
| Avg. Estimate | 17.28B | 14.31B | 63.05B | 63.02B |
| Low Estimate | 16.1B | 14.04B | 61.97B | 61.01B |
| High Estimate | 18.1B | 14.95B | 63.92B | 64.11B |
| Year Ago Sales | 14.25B | 14.88B | 58.5B | 63.05B |
| Sales Growth (year/est) | 21.24% | -3.84% | 7.79% | -0.06% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PFE.CL | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 1/8/2025 |
| Maintains | Truist Securities: Buy to Buy | 12/18/2024 |
| Maintains | Guggenheim: Buy to Buy | 12/11/2024 |
| Initiated | Wolfe Research: Underperform | 11/15/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/25/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/23/2024 |
Related Tickers
GS71.DU GSK PLC
16.16
+0.28%
AMG.HA Amgen Inc
261.50
-0.59%
0O59.IL Sanofi
100.16
+0.25%
JNJ.CL Johnson & Johnson
626,500.00
0.00%
AMGN.MX Amgen Inc.
5,660.00
0.00%
MRK.VI Merck & Co., Inc.
91.10
-1.41%
BAYA.BE Bayer AG
5.20
-1.89%
ZEG.F AstraZeneca PLC
131.85
-0.08%
SNW.F Sanofi
100.04
+0.46%
BRM.F Bristol-Myers Squibb Company
57.22
+2.36%